BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 9695216)

  • 21. Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide.
    Houssiau FA; Vasconcelos C; D'Cruz D; Sebastiani GD; Garrido Ed Ede R; Danieli MG; Abramovicz D; Blockmans D; Mathieu A; Direskeneli H; Galeazzi M; Gül A; Levy Y; Petera P; Popovic R; Petrovic R; Sinico RA; Cattaneo R; Font J; Depresseux G; Cosyns JP; Cervera R
    Arthritis Rheum; 2002 Aug; 46(8):2121-31. PubMed ID: 12209517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.
    De Groot K; Rasmussen N; Bacon PA; Tervaert JW; Feighery C; Gregorini G; Gross WL; Luqmani R; Jayne DR
    Arthritis Rheum; 2005 Aug; 52(8):2461-9. PubMed ID: 16052573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of steroids, cyclosporin and cyclophos-phamide in steroid resistant idiopathic nephrotic syndrome.
    Hafeez F; Ahmad TM; Anwar S
    J Coll Physicians Surg Pak; 2005 Jun; 15(6):329-32. PubMed ID: 15924835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma.
    Hoyles RK; Ellis RW; Wellsbury J; Lees B; Newlands P; Goh NS; Roberts C; Desai S; Herrick AL; McHugh NJ; Foley NM; Pearson SB; Emery P; Veale DJ; Denton CP; Wells AU; Black CM; du Bois RM
    Arthritis Rheum; 2006 Dec; 54(12):3962-70. PubMed ID: 17133610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of pulse and oral steroid in childhood membranoproliferative glomerulonephritis.
    Bahat E; Akkaya BK; Akman S; Karpuzoglu G; Guven AG
    J Nephrol; 2007; 20(2):234-45. PubMed ID: 17514629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Study Group.
    Branten AJ; Wetzels JF
    Clin Nephrol; 2001 Jul; 56(1):1-9. PubMed ID: 11499653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Results of immunosuppressive therapy of chronic glomerulonephritis in 400 patients].
    Müller V; Natusch R; Göbel U; Laske HR; Sperschneider H; Pap I; Sinn W; Koall W; Achenbach H; Tredt HJ
    Z Urol Nephrol; 1985 Jan; 78(1):39-55. PubMed ID: 3976309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. EULAR randomised controlled trial of pulse cyclophosphamide and methylprednisolone versus continuous cyclophosphamide and prednisolone followed by azathioprine and prednisolone in lupus nephritis.
    Yee CS; Gordon C; Dostal C; Petera P; Dadoniene J; Griffiths B; Rozman B; Isenberg DA; Sturfelt G; Nived O; Turney JH; Venalis A; Adu D; Smolen JS; Emery P
    Ann Rheum Dis; 2004 May; 63(5):525-9. PubMed ID: 15082482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of a second course of immunosuppressive therapy in patients with membranous nephropathy and persistent or relapsing disease activity.
    du Buf-Vereijken PW; Wetzels JF
    Nephrol Dial Transplant; 2004 Aug; 19(8):2036-43. PubMed ID: 15187191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Follow-up of linear growth of body height in children with nephrotic syndrome.
    Hung YT; Yang LY
    J Microbiol Immunol Infect; 2006 Oct; 39(5):422-5. PubMed ID: 17066206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term outcomes of idiopathic membranous nephropathy in Japanese patients treated with low-dose cyclophosphamide and prednisolone.
    Eriguchi M; Oka H; Mizobuchi T; Kamimura T; Sugawara K; Harada A
    Nephrol Dial Transplant; 2009 Oct; 24(10):3082-8. PubMed ID: 19465558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The course and prognosis of mesangioproliferative glomerulonephritis].
    Shilov EM; Tareeva IE; Ivanov AA; Troepol'skaia OV; Krasnova TN; Varshavskiĭ VA; Proskurneva EP; Ivanova LV; Khudova IIu; Miroshnichenko NG
    Ter Arkh; 2002; 74(6):11-8. PubMed ID: 12136475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tacrolimus versus intravenous pulse cyclophosphamide therapy in Chinese adults with steroid-resistant idiopathic minimal change nephropathy: a multicenter, open-label, nonrandomized cohort trial.
    Li H; Shi X; Shen H; Li X; Wang H; Li H; Xu G; Chen J
    Clin Ther; 2012 May; 34(5):1112-20. PubMed ID: 22503105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term outcome of diffuse proliferative lupus glomerulonephritis treated with cyclophosphamide.
    Mok CC; Ying KY; Ng WL; Lee KW; To CH; Lau CS; Wong RW; Au TC
    Am J Med; 2006 Apr; 119(4):355.e25-33. PubMed ID: 16564783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Difficult-to-treat nephrotic syndrome: management and outcome.
    Sumboonnanonda A; Chongchate N; Suntornpoch V; Pattaragarn A; Supavekin S
    J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S142-8. PubMed ID: 16856434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early versus late start of immunosuppressive therapy in idiopathic membranous nephropathy: a randomized controlled trial.
    Hofstra JM; Branten AJ; Wirtz JJ; Noordzij TC; du Buf-Vereijken PW; Wetzels JF
    Nephrol Dial Transplant; 2010 Jan; 25(1):129-36. PubMed ID: 19666912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The treatment of chronic glomerulonephritis with ultrahigh doses of cyclophosphane].
    Krasnova TN; Shilov EM; Ivanov AA; Samoĭlov DV; Gordovskaia NB; Miroshnichenko NG; Tareeva IE
    Ter Arkh; 1991; 63(6):115-8. PubMed ID: 1948725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of immunosuppressive therapeutic regimens in patients with nephrotic syndrome due to idiopathic membranous nephropathy.
    Kosmadakis G; Filiopoulos V; Smirloglou D; Skarlas P; Georgoulias C; Michail S
    Ren Fail; 2010 Jun; 32(5):566-71. PubMed ID: 20486839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined therapy of low-dose tacrolimus and prednisone in nephrotic syndrome with slight mesangial proliferation.
    Miao L; Sun J; Yuan H; Jia Y; Xu Z
    Nephrology (Carlton); 2006 Oct; 11(5):449-54. PubMed ID: 17014560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A controlled clinical trial of Consupren versus cyclophosphamide in chronic glomerulonephritis].
    Matl I; Matousovic K; Herout V; Konecný K; Kovác A; Rychlík I; Sobotová D; Roland R; Zdichyncová I; Lánská V
    Cas Lek Cesk; 1997 Feb; 136(4):120-3. PubMed ID: 9221182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.